University of Dundee

all News

October 2013

  • Mike Ferguson and Pete Downes
    03 Oct 2013

    The University of Dundee has won a record level of research funding in the year spanning 2012/13 with awards totalling around £140 million. Income from research funding significantly outstripped the previous year’s total of £114 million, which was itself a new high for Dundee and regarded as being exceptional. The figures for 2012/13 once again reflect a particularly strong performance in funding for Life Sciences, boosted by major awards including £24 million from the Medical Research Council to support the MRC Protein Phosphorylation and Ubiquitylation Unit.

  • Karim Labib's lab, Left-Right: Pedro Nkosi, Marija Maric, Cecile Evrin and Karim Labib
    01 Oct 2013

    Karim Labib and his current lab, consisting of Pedro Nkosi (Senior Scientific Officer), Marija Maric (PhD student) and Cecile Evrin (postdoc), have joined the MRC Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU). Karim will take up a senior group leader position within the MRC-PPU and he will also become Dundee University’s Professor of Genome Integrity. Image note: Karim Labib's lab, Left-Right: Pedro Nkosi, Marija Maric, Cecile Evrin and Karim Labib

  • Lina Herhaus
    01 Oct 2013

    The TGFβ signalling pathway controls plethora of cellular functions during embryogenesis and in adult tissues. Consequently abnormal TGFβ signalling is associated with multiple human diseases such as fibrosis, immune disorders and cancer. TGFβ signalling is initiated upon ligand binding to a pair of receptor serine/threonine protein kinases on the cell surface. This triggers the phosphorylation of SMAD2/3 leading to the assembly and nuclear translocation of active SMAD2/3/4 transcriptional complex, which, together with other co-factors, drives the transcription of hundreds of target genes.

September 2013

August 2013

  • Vicky Cowling
    05 Aug 2013

    Dr Victoria Cowling, of the College of Life Sciences at the University of Dundee, has been awarded a prestigious Medical Research Council Senior Non-Clinical Fellowship to continue her ground breaking research on how mutations in cancer genes can result in tumours forming. The Fellowship will provide Dr Cowling, who is based in the Medical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) at Dundee, with £2.5million over seven years to build upon the discoveries that her research group has made over the last five years.

July 2013

June 2013